Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.750
+0.080 (4.79%)
At close: Mar 25, 2026, 4:00 PM EDT
1.780
+0.030 (1.70%)
After-hours: Mar 25, 2026, 7:59 PM EDT
Codexis Employees
Codexis had 146 employees as of December 31, 2025. The number of employees decreased by 42 or -22.34% compared to the previous year.
Employees
146
Change (1Y)
-42
Growth (1Y)
-22.34%
Revenue / Employee
$482,103
Profits / Employee
-$301,192
Market Cap
159.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 146 | -42 | -22.34% | 146 | 0 |
| Dec 31, 2024 | 188 | 14 | 8.05% | 188 | 0 |
| Dec 31, 2023 | 174 | -74 | -29.84% | 174 | 0 |
| Dec 31, 2022 | 248 | -13 | -4.98% | 248 | 0 |
| Dec 31, 2021 | 261 | 80 | 44.20% | 261 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Molecular Partners AG | 134 |
| Cartesian Therapeutics | 75 |
| Tenaya Therapeutics | 70 |
| Precision BioSciences | 68 |
| Acumen Pharmaceuticals | 61 |
| Korro Bio | 58 |
| Evaxion | 46 |
CDXS News
- 13 days ago - Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform - Seeking Alpha
- 14 days ago - Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 21 days ago - Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - PRNewsWire
- 4 weeks ago - Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 - GlobeNewsWire
- 6 weeks ago - Codexis Achieves ISO 9001:2015 Certification - GlobeNewsWire
- 2 months ago - Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - PRNewsWire
- 4 months ago - Codexis Announces Signing of Lease for GMP Manufacturing Facility - GlobeNewsWire